Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessment

C Chargari, KM Kirov, MA Bollet, N Magné… - Cancer treatment …, 2011 - Elsevier
When focusing on heart disease, most available studies split the two different parts of the
adjuvant treatment, ie, systemic therapies and radiation therapy, making it difficult to …

Advancing the Collaboration Between Imaging and Radiation Oncology

X Jia, BW Carter, A Duffton, E Harris, R Hobbs… - Seminars in Radiation …, 2024 - Elsevier
The fusion of cutting-edge imaging technologies with radiation therapy (RT) has catalyzed
transformative breakthroughs in cancer treatment in recent decades. It is critical for us to …

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial

D Azria, Y Belkacemi, G Romieu, S Gourgou… - The lancet …, 2010 - thelancet.com
Background Letrozole radiosensitises breast cancer cells in vitro. In clinical settings, no data
exist for the combination of letrozole and radiotherapy. We assessed concurrent and …

Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double‐strand DNA break repair

C Alonso‐González, A González… - Journal of pineal …, 2015 - Wiley Online Library
Radiation and adjuvant endocrine therapy are nowadays considered a standard treatment
option after surgery in breast cancer. Melatonin exerts oncostatic actions on human breast …

Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis

C Alonso-González, A González, C Martínez-Campa… - Cancer letters, 2016 - Elsevier
Enhancing the radiosensitivity of cancer cells is one of the most important tasks in clinical
radiobiology. Endocrine therapy and radiotherapy are two cancer treatment modalities …

Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer

I Meattini, M Guenzi, A Fozza, C Vidali, P Rovea… - Breast Cancer, 2017 - Springer
Conservative management of breast cancer represents the standard treatment for early
disease. Breast conserving surgery associated with radiotherapy for stage I-II has been …

Integrating nanomedicine into clinical radiotherapy regimens

AN DuRoss, MJ Neufeld, S Rana, CR Thomas Jr… - Advanced drug delivery …, 2019 - Elsevier
While the advancement of clinical radiotherapy was driven by technological innovations
throughout the 20th century, continued improvement relies on rational combination …

[HTML][HTML] Preoperative radiotherapy in breast cancer patients: 32 years of follow-up

FG Riet, F Fayard, R Arriagada, MA Santos… - European Journal of …, 2017 - Elsevier
This study evaluates the long-term outcomes of a retrospective cohort of breast cancer (BC)
patients who had received curatively intended premastectomy radiation therapy (RT). We …

A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines

A Vessières, C Corbet, JM Heldt, N Lories… - Journal of inorganic …, 2010 - Elsevier
The aim of this work was to investigate the mechanism of action of ferrocifen (Fc-OH-TAM),
the ferrocenyl analog of 4-hydroxy-tamoxifen (OH-TAM), which is the active metabolite of …

Estrogen receptor signaling in radiotherapy: from molecular mechanisms to clinical studies

C Rong, ÉFRC Meinert, J Hess - International journal of molecular …, 2018 - mdpi.com
Numerous studies have established a proof of concept that abnormal expression and
function of estrogen receptors (ER) are crucial processes in initiation and development of …